A carregar...
Engineering multi-specific antibodies against HIV-1
As increasing numbers of broadly neutralizing monoclonal antibodies (mAbs) against HIV-1 enter clinical trials, it is becoming evident that combinations of mAbs are necessary to block infection by the diverse array of globally circulating HIV-1 strains and to limit the emergence of resistant viruses...
Na minha lista:
| Publicado no: | Retrovirology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6114543/ https://ncbi.nlm.nih.gov/pubmed/30157871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-018-0439-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|